Results 71 to 80 of about 6,737 (128)

HCB101: a novel potent ligand-trap Fc-fusion protein targeting the CD47-SIRPα pathway with high safety and preclinical efficacy for hematological and solid tumors. [PDF]

open access: yesJ Hematol Oncol
Wang JT   +21 more
europepmc   +1 more source

Inhibition of HERG1 K+ channel protein expression decreases cell proliferation of human small cell lung cancer cells [PDF]

open access: yes, 2011
Günter Glassmeier   +5 more
core   +1 more source

PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibition. [PDF]

open access: yesCommun Biol
Kopparam J   +11 more
europepmc   +1 more source

S100A9 enhances tumor immune suppression and cancer cell survival in small cell lung cancer. [PDF]

open access: yesCell Death Dis
Charan M   +7 more
europepmc   +1 more source

The Impact of Targeting TRAF2 and NCK-Interacting Protein Kinase on Antitumor Effect and Tumor Immune Environment in c-MYC-High SCLC. [PDF]

open access: yesJ Thorac Oncol
Tanimoto A   +10 more
europepmc   +1 more source

Synthetic lethality between RB-loss and E2F3 inhibition in small cell cancers targeted by pyrimidine synthesis blockade. [PDF]

open access: yesProc Natl Acad Sci U S A
Abt ER   +16 more
europepmc   +1 more source

KSR1 Mediates Small Cell Lung Carcinoma Tumor Initiation and Cisplatin Resistance. [PDF]

open access: yesMol Cancer Res
Chatterjee D   +8 more
europepmc   +1 more source

The protease cathepsin K can debulk the cancer glycocalyx. [PDF]

open access: yesJ Biol Chem
Kuo A   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy